A method for producing an organometallic nucleophile includes reacting an organohalide and a metal or metal compound with each other by a mechanochemical process in the presence of an ether compound in an amount of 0.5 to 10.0 equivalents relative to 1 equivalent of the organohalide. By utilizing the method, a method for producing an organometallic nucleophile can be performed without using a large-scale apparatus, a reaction method for reactions between an organometallic nucleophile and various organic electrophiles can be performed by an efficient and simplified means, and a simplified method for producing an organometallic nucleophile can be performed with high reactivity.

A method for producing an organometallic nucleophile includes reacting an organohalide and a metal or metal compound with each other by a mechanochemical process in the presence of an ether compound in an amount of 0.5 to 10.0 equivalents relative to 1 equivalent of the organohalide. By utilizing the method, a method for producing an organometallic nucleophile can be performed without using a large-scale apparatus, a reaction method for reactions between an organometallic nucleophile and various organic electrophiles can be performed by an efficient and simplified means, and a simplified method for producing an organometallic nucleophile can be performed with high reactivity.

The present invention relates to processes of preparing N-((1,2,3,4,5,6,7-hexahydro-s-indacen-4-yl)carbamoyl)-1-iso-propyl-1H-pyrazole-3-sulfonamide and salts thereof. The present invention further relates to pharmaceutical compositions comprising such compounds and to the use of such compounds in the treatment and prevention of medical disorders and diseases, most especially by NLRP3 inhibition.

The present invention relates to processes of preparing N-((1,2,3,4,5,6,7-hexahydro-s-indacen-4-yl)carbamoyl)-1-iso-propyl-1H-pyrazole-3-sulfonamide and salts thereof. The present invention further relates to pharmaceutical compositions comprising such compounds and to the use of such compounds in the treatment and prevention of medical disorders and diseases, most especially by NLRP3 inhibition.

A process is disclosed for producing renewable products, such as a renewable base oil, from a feedstock of biological origin. The process includes subjecting a feedstock containing free fatty acids and fatty acid glycerides, wherein at least one hydrocarbon chain is unsaturated, to esterification reaction in the presence of an alcohol. An ester stream thereby obtained is then subjected to metathesis conditions in the presence of a renewable alkene to obtain a metathesis product. Separation of the metathesis product includes recovery of a fraction containing or consisting essentially of C16 fatty acid esters, which is subjected to ketonisation reaction conditions to produce long chain ketones, which after hydrotreatment meet requirements for a renewable base oil. Ketonisation reaction produces renewable alkene usable in metathesis reaction.

A process is disclosed for producing renewable products, such as a renewable base oil, from a feedstock of biological origin. The process includes subjecting a feedstock containing free fatty acids and fatty acid glycerides, wherein at least one hydrocarbon chain is unsaturated, to esterification reaction in the presence of an alcohol. An ester stream thereby obtained is then subjected to metathesis conditions in the presence of a renewable alkene to obtain a metathesis product. Separation of the metathesis product includes recovery of a fraction containing or consisting essentially of C16 fatty acid esters, which is subjected to ketonisation reaction conditions to produce long chain ketones, which after hydrotreatment meet requirements for a renewable base oil. Ketonisation reaction produces renewable alkene usable in metathesis reaction.

Provided herein are methods for preparing ketone-containing organic molecules. The methods are based on novel iron/copper-mediated (“Fe/Cu-mediated”) coupling reactions. The Fe/Cu-mediated coupling reaction can be used in the preparation of complex molecules, such as halichondrins and analogs thereof. In particular, the Fe/Cu-mediated ketolization reactions described herein are useful in the preparation of intermediates en route to halichondrins.

##STR00001##

Production apparatus of triptane includes: carbon dioxide recovery unit configured to recover carbon dioxide from air; hydrogen generation unit configured to electrolyze water by renewable electricity to generate hydrogen; carbon monoxide generation unit configured to generate carbon monoxide from recovered carbon dioxide and hydrogen generated; methanol generation unit configured to generate methanol from carbon monoxide generated and hydrogen generated; acetic acid generation unit configured to generate acetic acid by reacting methanol generated with recovered carbon dioxide or with carbon monoxide generated; acetone generation unit configured to generate acetone and carbon dioxide from acetic acid generated; pinacolone generation unit configured to generate pinacolone from acetone generated; Grignard reagent generation unit configured to generate Grignard reagent from methanol generated; trimethyl butanol generation unit configured to generate 2,3,3-trimethyl-2-butanol by reacting pinacolone generated with Grignard reagent generated; and triptane generation unit configured to generate 2,2,3-trimethylbutane from 2,3,3-trimethyl-2-butanol generated.

Production apparatus of triptane includes: carbon dioxide recovery unit configured to recover carbon dioxide from air; hydrogen generation unit configured to electrolyze water by renewable electricity to generate hydrogen; carbon monoxide generation unit configured to generate carbon monoxide from recovered carbon dioxide and hydrogen generated; methanol generation unit configured to generate methanol from carbon monoxide generated and hydrogen generated; acetic acid generation unit configured to generate acetic acid by reacting methanol generated with recovered carbon dioxide or with carbon monoxide generated; acetone generation unit configured to generate acetone and carbon dioxide from acetic acid generated; pinacolone generation unit configured to generate pinacolone from acetone generated; Grignard reagent generation unit configured to generate Grignard reagent from methanol generated; trimethyl butanol generation unit configured to generate 2,3,3-trimethyl-2-butanol by reacting pinacolone generated with Grignard reagent generated; and triptane generation unit configured to generate 2,2,3-trimethylbutane from 2,3,3-trimethyl-2-butanol generated.

The present disclosure provides a process for preparing an aryl ketone of Formula I, comprising reacting a substituted benzene of Formula II with a carboxylic acid of formula IIIa and/or a carboxylic anhydride of formula IIIb in presence of an alkyl sulfonic acid acting as catalyst cum solvent/contacting medium. I, II, IIIa, IIIb, wherein, R.sub.1, R.sub.2, R.sub.3 and R.sub.4 are as defined in the description. ##STR00001##